Whittier Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Whittier Trust’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-32	Closed	-$3K	–	1544
2021 Q2	$3K	Hold	32	–	–	﹤0.01%	1412
2021 Q1	$3K	Hold	32	–	–	﹤0.01%	1410
2020 Q4	$2K	Hold	32	–	–	﹤0.01%	1326
2020 Q3	$2K	Buy	+32	New	+$2.18K	﹤0.01%	1336
2020 Q2	–	Sell	-32	Closed	-$1K	–	1457
2020 Q1	$1K	Hold	32	–	–	﹤0.01%	1397
2019 Q4	$2K	Hold	32	–	–	﹤0.01%	1368
2019 Q3	$2K	Hold	32	–	–	﹤0.01%	1380
2019 Q2	$2K	Hold	32	–	–	﹤0.01%	1225
2019 Q1	$3K	Hold	32	–	–	﹤0.01%	1175
2018 Q4	$3K	Hold	32	–	–	﹤0.01%	1209
2018 Q3	$5K	Hold	32	–	–	﹤0.01%	1115
2018 Q2	$4K	Hold	32	–	–	﹤0.01%	1120
2018 Q1	$3K	Hold	32	–	–	﹤0.01%	1186
2017 Q4	$3K	Hold	32	–	–	﹤0.01%	1169
2017 Q3	$3K	Hold	32	–	–	﹤0.01%	1198
2017 Q2	$2K	Hold	32	–	–	﹤0.01%	1162
2017 Q1	$2K	Hold	32	–	–	﹤0.01%	1265
2016 Q4	$2K	Hold	32	–	–	﹤0.01%	1115
2016 Q3	$2K	Hold	32	–	–	﹤0.01%	1114
2016 Q2	$2K	Hold	32	–	–	﹤0.01%	1133
2016 Q1	$2K	Hold	32	–	–	﹤0.01%	1112
2015 Q4	$2K	Buy	+32	New	+$1.98K	﹤0.01%	1120

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Whittier Trust's LGND Position: Q3 2021 in Review

Whittier Trust sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 32 shares — an estimated $3K sold.

Whittier Trust first reported a position in LGND in Q4 2015 and held it in 22 quarters. The position peaked at $5K in Q3 2018. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

Whittier Trust reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Whittier Trust sold 32 Ligand Pharmaceuticals shares in Q3 2021, an estimated $3K.
Whittier Trust first reported a position in Ligand Pharmaceuticals in Q4 2015 and held it in 22 quarters.
Whittier Trust's Ligand Pharmaceuticals position peaked at $5K in Q3 2018.
207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Whittier Trust's 13F filing for Q3 2021, filed 1 Nov 2021.